All terms in GO

Label Id Description
aminoglycoside antibiotic catabolic process GO_0030649 [The chemical reactions and pathways resulting in the breakdown of an aminoglycoside antibiotic, any member of a group of broad spectrum antibiotics, of similar toxicity and pharmacology, that contain an aminodeoxysugar, an amino- or guanidino-substituted inositol ring, and one or more residues of other sugars. The group includes streptomycin, neomycin, framycetin, kanamycin, paromomycin, and gentamicin.]
vistamycin biosynthetic process GO_1901152 [The chemical reactions and pathways resulting in the formation of vistamycin.]
negative regulation of intermediate mesodermal cell fate determination GO_0048396 [Any process that stops, prevents, or reduces the frequency, rate or extent of intermediate mesoderm cell fate determination.]
paromomycin metabolic process GO_1901153 [The chemical reactions and pathways involving paromomycin.]
paromomycin catabolic process GO_1901154 [The chemical reactions and pathways resulting in the breakdown of paromomycin.]
paromomycin biosynthetic process GO_1901155 [The chemical reactions and pathways resulting in the formation of paromomycin.]
neomycin metabolic process GO_1901156 [The chemical reactions and pathways involving neomycin.]
neomycin catabolic process GO_1901157 [The chemical reactions and pathways resulting in the breakdown of neomycin.]
neomycin biosynthetic process GO_1901158 [The chemical reactions and pathways resulting in the formation of neomycin.]
intermediate mesoderm morphogenesis GO_0048390 [The process in which the anatomical structures of the intermediate mesoderm are generated and organized.]
endosomal lumen acidification GO_0048388 [Any process that reduces the pH of the endosomal lumen, measured by the concentration of the hydrogen ion.]
intracellular pH reduction GO_0051452 [Any process that reduces the internal pH of a cell, measured by the concentration of the hydrogen ion.]
intermediate mesoderm development GO_0048389 [The process whose specific outcome is the progression of the intermediate mesoderm over time, from its formation to the mature structure. The intermediate mesoderm is located between the lateral mesoderm and the paraxial mesoderm. It develops into the kidney and gonads.]
mesendoderm development GO_0048382 [The process whose specific outcome is the progression of the mesendoderm over time, from its formation to the mature structure. In animal embryos, mesendoderm development gives rise to both mesoderm and endoderm tissues.]
mesectoderm development GO_0048383 [The process whose specific outcome is the progression of the mesectoderm over time, from its formation to the mature structure. In animal embryos, mesectoderm development processes give rise to both mesoderm and ectoderm tissues.]
negative regulation of lateral mesodermal cell fate specification GO_0048380 [Any process that stops, prevents, or reduces the frequency, rate or extent of lateral mesoderm cell fate specification.]
lateral mesoderm structural organization GO_0048381 [The process that contributes to the act of creating the structural organization of the lateral mesoderm. This process pertains to the physical shaping of a rudimentary structure.]
positive regulation of retinoic acid receptor signaling pathway GO_0048386 [Any process that activates or increases the frequency, rate or extent of retinoic acid receptor signaling pathway activity.]
regulation of retinoic acid receptor signaling pathway GO_0048385 [Any process that modulates the frequency, rate or extent of retinoic acid receptor signaling pathway activity.]
negative regulation of retinoic acid receptor signaling pathway GO_0048387 [Any process that stops, prevents, or reduces the frequency, rate or extent of retinoic acid receptor signaling pathway activity.]